APA:
Copy. (2021). Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma. MOLECULAR MEDICINE, 27(1), 1-3. SID. https://sid.ir/paper/1023884/en
Vancouver:
Copy. Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma. MOLECULAR MEDICINE[Internet]. 2021;27(1):1-3. Available from: https://sid.ir/paper/1023884/en
IEEE:
Copy, “Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma,” MOLECULAR MEDICINE, vol. 27, no. 1, pp. 1–3, 2021, [Online]. Available: https://sid.ir/paper/1023884/en